Results 51 to 60 of about 285,924 (259)

Dynamical fluctuations of a tracer coupled to active and passive particles

open access: yesJournal of Physics: Complexity, 2023
We study the induced dynamics of an inertial tracer particle elastically coupled to passive or active Brownian particles. We integrate out the environment degrees of freedom to obtain the exact effective equation of the tracer—a generalized Langevin ...
Ion Santra
doaj   +1 more source

Liver organoids: modelling complexity in homeostasis and disease

open access: yesFEBS Letters, EarlyView.
Studying liver in vitro has been challenging because simple 2D cell cultures fail to capture liver's cellular and architectural complexity. To bridge this gap, scientists increasingly use organoids, 3D liver models which better mimic liver composition and function. This review examines recent advances in liver organoid complexity and realism, discusses
Anna M. Dowbaj, Meritxell Huch
wiley   +1 more source

Temporal moments of a tracer pulse in a perfectly parallel flow system [PDF]

open access: yes, 2002
Perfectly parallel groundwater transport models partition water flow into isolated one-dimensional stream tubes which maintain total spatial correlation of all properties in the direction of flow.
W. E. Bardsley, Bardsley, W. Earl
core   +1 more source

Circumferential Viscodilation Ab Interno Combined with Phacoemulsification for Treatment of Open-Angle Glaucoma: 12-Month Outcomes

open access: yesClinical Ophthalmology, 2020
Nathaniel Tracer,1 Jaime E Dickerson Jr,2,3 Nathan M Radcliffe4 1NYU School of Medicine, New York, NY, USA; 2Sight Sciences, Inc, Menlo Park, CA, USA; 3North Texas Eye Research Institute, UNTHSC, Fort Worth, TX, USA; 4Mt Sinai School of Medicine, New ...
Tracer N, Dickerson JE Jr, Radcliffe NM
doaj  

Detection technology of micro residual core in small inner cavity of complex castings [PDF]

open access: yesChina Foundry, 2018
A new technology for detecting a tiny residual core in the small inner cavity of complex castings is proposed. The residual core is identified by using image recognition technology.
Jun-hao Zhao, *Shi-ping Wu, Yin Dong
doaj   +1 more source

Golgi enzymes are retrieved from the plasma membrane to the trans‐Golgi network

open access: yesFEBS Letters, EarlyView.
Golgi enzymes are traditionally considered resident proteins retained within the Golgi apparatus. Here, we demonstrate that a subset transiently reaches the cell surface and is subsequently retrieved to the trans‐Golgi network via retrograde transport. Using a nanobody‐based toolkit, we uncover a dynamic trafficking cycle of several Golgi enzymes.
Dominik P. Buser, Tina Junne
wiley   +1 more source

Introducing the TraCEr Lab, laboratory for traceology and controlled experiments (MONREPOS, RGZM)

open access: yes, 2018
*Podium presentatonMarreiros, J., Calandra, I., Gneisinger, W. 2017. Introducing the TraCEr Lab, laboratory for traceology andcontrolled experiments (MONREPOS, RGZM). AGSTR 2017.
TraCEr TraCEr (5212532)
core   +1 more source

Theoretical analysis of tracer method for the measurement of wetting efficiency [PDF]

open access: yes, 2007
This work investigates the tracer technique for the measurement of catalyst wetting efficiency, f, in trickle-bed reactor. The model of Ramachandran et al.
Baussaron, Loïc   +7 more
core   +1 more source

Ligand‐dependent transcriptional heterogeneity in cell cycle gene expression delays G1/S entry

open access: yesFEBS Letters, EarlyView.
EGF and HRG induce distinct G1/S progression programs in ErbB2‐amplified BT474 breast cancer cells. Despite activating the potent ErbB2–ErbB3 heterodimer, HRG does not accelerate cell‐cycle entry. Instead, EGF promotes earlier restriction‐point passage via ERK–FOS signaling, whereas HRG activates the AKT–MYC axis, driving transcriptional heterogeneity ...
Ririn Rahmala Febri   +5 more
wiley   +1 more source

Navigating the landscape of PD-1/PD-L1 imaging tracers: from challenges to opportunities

open access: yesFrontiers in Medicine
Immunotherapy targeted to immune checkpoint inhibitors, such as the program cell death receptor (PD-1) and its ligand (PD-L1), has revolutionized cancer treatment. However, it is now well-known that PD-1/PD-L1 immunotherapy response is inconsistent among
Melinda Badenhorst   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy